
President Donald Trump, dissuaded from mainlining Lysol, has talked his doctor into giving him hydroxychloroquine in an effort to prevent COVID-19. “The hydroxy,” as the president calls it, is an anti-malarial drug with zero proven effect in preventing or treating COVID-19 infection, and the FDA has warned of its cardiovascular risks. As of this writing, we are unaware of any movement to revoke the medical license of Sean Conley, D.O., current Physician to the President, over this matter.
President Trump’s reasons for ignoring prevailing advice on the risks in taking hydroxychloroquine?
- “You’d be surprised at how many people are taking it….”
- “I’ve heard a lot of good stories.”
- “I get a lot of positive calls about it.”
- “What the hell have you got to lose?”
More:
“Despite FDA Caution, Trump Says He Is Taking Hydroxychloroquine As A Preventive,” Joe Palca, NPR News
“Trump’s stunning claim that he’s taking hydroxychloroquine could trigger a cascade of negative effects,’ Philip Bump, Washington Post
“Trump Takes Hydroxychloroquine, Does Not Understand How Science Works,” Jonathan Chait, New York Magazine
“Trump Says He’s Taking Hydroxychloroquine, But He Also Lies Daily,” Peter Wade, Rolling Stone
Updates:
“Pence says he isn’t taking unproven hydroxychloroquine treatment for coronavirus that Trump takes,” Kevin Breuninger, CNBC
“Trump dismisses hydroxychloroquine study that undermines him as a ‘Trump enemy statement,’” aaron Rupar, Vox
“White House releases doctor’s note on Trump’s purported use of hydroxychloroquine,” Peter Weber, The Week
“Hydroxychloroquine Isn’t a Joke It’s a Scandal,” Josh Marshall, Talking Points Memo
“Antimalarial drug touted by President Trump is linked to increased risk of death in coronavirus patients, study says,” Ariana Eunjung Cha and Laurie McGinley, Washington Post
“Hydroxychloroquine: Trump’s Covid-19 ‘cure’ increases deaths, global study finds,” Sarah Boseley, The Guardian
___________________
Short Link: https://wp.me/p6sb6-uZk
Image by Mike Licht. Download a copy here. Creative Commons license; credit Mike Licht, NotionsCapital.com
Comments are welcome if they are on-topic, substantive, concise, and not boring or obscene. Comments may be edited for clarity and length.